Articles tagged with Differentiated Cells
Researchers developed tiny human ovary organoids using stem cells to understand gonad development and disease. The models replicate key aspects of ovarian follicles, offering a powerful platform for studying gene function in a controlled environment.
A new study from the CUNY Graduate Center uncovers key mechanisms responsible for the transformation of adult progenitor cells into brain tumors. Researchers found that a specific combination of genetic mutations and growth factor overproduction drives this transformation, highlighting the importance of epigenetic changes in glioma dev...
Researchers at CUNY ASRC identify distinct histone tag in adult oligodendrocyte progenitor cells that regulates their proliferation and may lead to innovative therapies for neurodegenerative diseases. The discovery holds promise for advancing myelin repair and improving patient outcomes.
A collaborative study by researchers at the University of Ottawa and McMaster University has made a groundbreaking discovery linking different types of cancers to their embryonic origins. The team found that drugs targeting specific embryonic pathways can effectively treat various tumors, including brain, colon, and leukemia cancers.
Researchers at UNIGE and FMI successfully modified the structure and function of tentacle cells in hydra by reducing Zic4 expression, resulting in transdifferentiation into foot cells. The study provides new insights into transdifferentiation mechanisms and could pave the way for therapies to regenerate deficient cell types in humans.
Researchers at the Lewis Katz School of Medicine defined 11 subsets of cells found in esophageal tissue using single cell gene-expression profiling. This study could help clinicians diagnose or treat certain types of cancer by identifying functional cell types contributing to cancer progression.
A team from UNIGE demonstrates that stem cells giving rise to beta cells cease to exist after birth, and defines the 'identity card' of other hormone-producing cells. This discovery has significant implications for developing cell-based therapies to treat diabetes.
Researchers identified a signature of nonresponse to CAR T therapy in leukemia cells, characterized by DNA methylation and stem cell-like phenotypes. Decreased expression of genes involved in antigen presentation also hindered the immune response.
Scientists from the University of Johannesburg found that shining two lasers on adult stem cells accelerates their transformation into different types of cells. The consecutive irradiation increases proliferation and differentiation under laboratory conditions, paving the way for potential therapies to repair damaged tissues.
A new study finds that autodegredation, a process where mature cells break down specialized structures, enables regeneration in adult tissues. Genes Atf3 and Rab7b are upregulated during this process, allowing cells to return to the cell cycle and potentially contributing to cancer development.
Researchers from the Center for Genomic Regulation discover Phf19 crucial for hematopoietic stem cell differentiation and balanced blood tissue. Without Phf19, mice develop disorders in blood composition compatible with early stages of leukemia.
Researchers at UW-Madison have developed a new approach to induce pluripotent stem cell generation, increasing efficiency from 5% to 40% and shortening the process. This breakthrough could lead to significant advancements in regenerative therapies and precision medicine.
Researchers found that blocking PRMT5 forces resistant brain-tumor cells into senescence, slowing or stopping tumor growth. This approach may offer a new treatment option for patients with glioblastoma.
Japanese researchers used iPS cell technology to increase the number of invariant natural killer T (iNKT) cells, which are rare helper immune cells that can activate cytotoxic cells against cancer. The creation of potent iNKT cells has important implications for understanding immune cell formation and developing new cancer therapies.
A team of scientists at Ludwig-Maximilians-Universität München has identified a new genetic switching element responsible for converting pluripotent stem cells into differentiated cell types. The discovery reveals that specific proteins recognize hydroxymethyluracil, a modified DNA base, to regulate gene activity in stem cells.
Researchers at Stanford University School of Medicine have developed a way to remove pluripotent human embryonic stem cells from their progeny before transplanted into patients. The technique uses antibodies to recognize and bind to only pluripotent cells, eliminating the risk of teratomas.
Researchers from Singapore's A*STAR report a novel transcription factor, Nr5a2, can replace classical reprogramming factors to increase iPS cell efficiency. This breakthrough has significant implications for cell-therapy-based medicine and the creation of organs for replacement or transplantation.
Researchers discovered that growing mouse skin cells in spheres can lead to generation of cells with properties of cancer stem cells. The study found that mutation of the retinoblastoma tumor suppressor gene family led to reprogramming of differentiated cells into cancer stem cells.
Scientists at St. Jude Children's Research Hospital discovered that a specific differentiated cell type requires constant expression of the Prox1 gene to maintain its identity. In its absence, lymphatic endothelial cells reprogram into blood endothelial cells, gaining new characteristics.
Scientists have identified 22 genes that control embryonic stem cell fate, which could accelerate the use of stem cells in therapy and disease treatment. The genes help maintain a memory of stem cell identity, allowing them to correctly read signals that determine cell type.
Researchers have successfully reprogrammed fully mature, differentiated B cells into an embryonic-stem-cell-like state without using eggs. This breakthrough enables the creation of powerful mouse models for autoimmune diseases like multiple sclerosis and type 1 diabetes.
Researchers have discovered that human embryonic stem cell nuclei are the most deformable, followed by hematopoietic stem cells, which generate blood and tissue cells. The study reveals that lamin proteins play a key role in stabilizing the nucleus and controlling gene expression.
St. Jude researchers discover that the Six2 gene prevents kidney stem cells from differentiating, maintaining a source of undifferentiated stem cells needed for kidney growth. The absence of Six2 leads to smaller, non-functional kidneys in developing mice.
Researchers have successfully cloned mice using direct nuclear transfer from terminally differentiated natural killer T cells. The cloned pups and their placentas exhibit rearranged T cell receptor genomic loci specific to NKT cells, demonstrating that fully differentiated cell nuclei can support embryo and placenta development.
Researchers found that adult cells descended from renin-producing cells can re-express the renin gene in response to stress, revealing a 'memory' of their original lineage. This ability allows these cells to rapidly respond to changes in blood pressure and sodium levels.